The trademark MYOCOLCIN was filed by Pharmaselect International Beteiligungs GmbH, a corporation established under the laws of the Republic of Austria (the "Applicant"). The application was published for oppositions on February 10, 2022, and received undefined oppositions.
There are undefined Oppositions claimed against trademark.
The first opposition filed on May 8, 2022 by Novartis AG on Likelihood of confusion. the opponent was represented by Nordemann Czychowski & Partner Rechtsanwältinnen und Rechtsanwälte mbB and its proceedings were handled in English The second opposition filed on May 8, 2022 by Sandoz A/S on Likelihood of confusion. the opponent was represented by Nordemann Czychowski & Partner Rechtsanwältinnen und Rechtsanwälte mbB and its proceedings were handled in English
The application was filed in German, and German was also language of all opposition proceedings (English was selected as the second language).